Oncogenic ras alters sensitivity of mouse colonocytes to butyrate and fatty acid mediated growth arrest and apoptosis

Docosahexaenoic acid (DHA) and butyrate favorably modulate colonocyte proliferation and apoptosis. In order to elucidate how oncogenic Ras modulates responses to these chemopreventive nutrients, we incubated isogenic non-transformed and Ras malignant transformed mouse colon cells with butyrate and D...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2002-12, Vol.186 (1), p.29-35
Hauptverfasser: Turner, Nancy D, Zhang, Jianhu, Davidson, Laurie A, Lupton, Joanne R, Chapkin, Robert S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 35
container_issue 1
container_start_page 29
container_title Cancer letters
container_volume 186
creator Turner, Nancy D
Zhang, Jianhu
Davidson, Laurie A
Lupton, Joanne R
Chapkin, Robert S
description Docosahexaenoic acid (DHA) and butyrate favorably modulate colonocyte proliferation and apoptosis. In order to elucidate how oncogenic Ras modulates responses to these chemopreventive nutrients, we incubated isogenic non-transformed and Ras malignant transformed mouse colon cells with butyrate and DHA or linoleic acid (LA). Combining DHA with 1 mM butyrate decreased proliferation relative to LA or no PUFA treatment in both cell lines. At a higher butyrate dose (5 mM), caspase 3 activity was elevated to a greater extent in Ras transformed cells. Only non-transformed cells were sensitive to the apoptogenic effects of DHA, indicating that Ras transformation alters sensitivity to dietary chemopreventive agents.
doi_str_mv 10.1016/S0304-3835(02)00325-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72016652</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383502003257</els_id><sourcerecordid>3241471321</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-da0515827b60bd07bde6e85b7194214bb5d62a28fe921548fc70a226c9fdea813</originalsourceid><addsrcrecordid>eNqF0d9rFDEQB_AgFnut_glKQCz6sHWS3WyyTyLFH4VCH6rPIZvM1pS95EyylfvvTe8OC770KRA-M8zMl5DXDM4ZsP7jDbTQNa1qxXvgHwBaLhr5jKyYkryRg4LnZPWPHJOTnO8AQHRSvCDHjDPVguQrslwHG28xeEuTydTMBVOmGUP2xd_7sqVxouu4ZKQ2zjFEuy2YaYl0XMo2mYLUBEcnUyo11ju6Rufrt6O3Kf4pv6hJCXPZKbOJmxKzzy_J0WTmjK8O7yn5-fXLj4vvzdX1t8uLz1eN7QSUxhkQTCguxx5GB3J02KMSo2RDx1k3jsL13HA14cCZ6NRkJRjOeztMDo1i7Sk52_fdpPh7qWPotc8W59kErDtpyespe8GfhEwJELxTFb79D97FJYW6hGaVtD2vN69K7JVNMeeEk94kvzZpqxnoh_j0Lj79kI0GrnfxaVnr3hy6L2O942PVIa8K3h2AydbMUzLB-vzoum7ggxiq-7R3WK977zHpbD0GW7NJaIt20T8xyl8u37ed</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1505362304</pqid></control><display><type>article</type><title>Oncogenic ras alters sensitivity of mouse colonocytes to butyrate and fatty acid mediated growth arrest and apoptosis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Turner, Nancy D ; Zhang, Jianhu ; Davidson, Laurie A ; Lupton, Joanne R ; Chapkin, Robert S</creator><creatorcontrib>Turner, Nancy D ; Zhang, Jianhu ; Davidson, Laurie A ; Lupton, Joanne R ; Chapkin, Robert S</creatorcontrib><description>Docosahexaenoic acid (DHA) and butyrate favorably modulate colonocyte proliferation and apoptosis. In order to elucidate how oncogenic Ras modulates responses to these chemopreventive nutrients, we incubated isogenic non-transformed and Ras malignant transformed mouse colon cells with butyrate and DHA or linoleic acid (LA). Combining DHA with 1 mM butyrate decreased proliferation relative to LA or no PUFA treatment in both cell lines. At a higher butyrate dose (5 mM), caspase 3 activity was elevated to a greater extent in Ras transformed cells. Only non-transformed cells were sensitive to the apoptogenic effects of DHA, indicating that Ras transformation alters sensitivity to dietary chemopreventive agents.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/S0304-3835(02)00325-7</identifier><identifier>PMID: 12183072</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Animals ; Antineoplastic agents ; Apoptosis ; Apoptosis - drug effects ; Biological and medical sciences ; Butyrate ; Butyrates - pharmacology ; Cell culture ; Cell Division - drug effects ; Cell growth ; Chemotherapy ; Colon - cytology ; Colon - drug effects ; Colon cancer ; Colorectal cancer ; Deoxyribonucleic acid ; Dietary fiber ; Dissemination ; DNA ; DNA Adducts - metabolism ; Docosahexaenoic acid ; Docosahexaenoic Acids - pharmacology ; Dose-Response Relationship, Drug ; Experiments ; Fatty acids ; Fatty Acids, Omega-3 ; Fatty Acids, Unsaturated - pharmacology ; Fish oils ; Genes, ras - physiology ; Linoleic acid ; Linoleic Acid - pharmacology ; Medical sciences ; Mice ; Pharmacology. Drug treatments ; Proliferation ; Ras ; Space life sciences ; Triglycerides - pharmacology ; Tumor cell ; Tumors</subject><ispartof>Cancer letters, 2002-12, Vol.186 (1), p.29-35</ispartof><rights>2002 Elsevier Science Ireland Ltd</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Elsevier Limited Dec 1, 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-da0515827b60bd07bde6e85b7194214bb5d62a28fe921548fc70a226c9fdea813</citedby><cites>FETCH-LOGICAL-c450t-da0515827b60bd07bde6e85b7194214bb5d62a28fe921548fc70a226c9fdea813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0304-3835(02)00325-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14492959$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12183072$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Turner, Nancy D</creatorcontrib><creatorcontrib>Zhang, Jianhu</creatorcontrib><creatorcontrib>Davidson, Laurie A</creatorcontrib><creatorcontrib>Lupton, Joanne R</creatorcontrib><creatorcontrib>Chapkin, Robert S</creatorcontrib><title>Oncogenic ras alters sensitivity of mouse colonocytes to butyrate and fatty acid mediated growth arrest and apoptosis</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Docosahexaenoic acid (DHA) and butyrate favorably modulate colonocyte proliferation and apoptosis. In order to elucidate how oncogenic Ras modulates responses to these chemopreventive nutrients, we incubated isogenic non-transformed and Ras malignant transformed mouse colon cells with butyrate and DHA or linoleic acid (LA). Combining DHA with 1 mM butyrate decreased proliferation relative to LA or no PUFA treatment in both cell lines. At a higher butyrate dose (5 mM), caspase 3 activity was elevated to a greater extent in Ras transformed cells. Only non-transformed cells were sensitive to the apoptogenic effects of DHA, indicating that Ras transformation alters sensitivity to dietary chemopreventive agents.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Butyrate</subject><subject>Butyrates - pharmacology</subject><subject>Cell culture</subject><subject>Cell Division - drug effects</subject><subject>Cell growth</subject><subject>Chemotherapy</subject><subject>Colon - cytology</subject><subject>Colon - drug effects</subject><subject>Colon cancer</subject><subject>Colorectal cancer</subject><subject>Deoxyribonucleic acid</subject><subject>Dietary fiber</subject><subject>Dissemination</subject><subject>DNA</subject><subject>DNA Adducts - metabolism</subject><subject>Docosahexaenoic acid</subject><subject>Docosahexaenoic Acids - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Experiments</subject><subject>Fatty acids</subject><subject>Fatty Acids, Omega-3</subject><subject>Fatty Acids, Unsaturated - pharmacology</subject><subject>Fish oils</subject><subject>Genes, ras - physiology</subject><subject>Linoleic acid</subject><subject>Linoleic Acid - pharmacology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Pharmacology. Drug treatments</subject><subject>Proliferation</subject><subject>Ras</subject><subject>Space life sciences</subject><subject>Triglycerides - pharmacology</subject><subject>Tumor cell</subject><subject>Tumors</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0d9rFDEQB_AgFnut_glKQCz6sHWS3WyyTyLFH4VCH6rPIZvM1pS95EyylfvvTe8OC770KRA-M8zMl5DXDM4ZsP7jDbTQNa1qxXvgHwBaLhr5jKyYkryRg4LnZPWPHJOTnO8AQHRSvCDHjDPVguQrslwHG28xeEuTydTMBVOmGUP2xd_7sqVxouu4ZKQ2zjFEuy2YaYl0XMo2mYLUBEcnUyo11ju6Rufrt6O3Kf4pv6hJCXPZKbOJmxKzzy_J0WTmjK8O7yn5-fXLj4vvzdX1t8uLz1eN7QSUxhkQTCguxx5GB3J02KMSo2RDx1k3jsL13HA14cCZ6NRkJRjOeztMDo1i7Sk52_fdpPh7qWPotc8W59kErDtpyespe8GfhEwJELxTFb79D97FJYW6hGaVtD2vN69K7JVNMeeEk94kvzZpqxnoh_j0Lj79kI0GrnfxaVnr3hy6L2O942PVIa8K3h2AydbMUzLB-vzoum7ggxiq-7R3WK977zHpbD0GW7NJaIt20T8xyl8u37ed</recordid><startdate>20021201</startdate><enddate>20021201</enddate><creator>Turner, Nancy D</creator><creator>Zhang, Jianhu</creator><creator>Davidson, Laurie A</creator><creator>Lupton, Joanne R</creator><creator>Chapkin, Robert S</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20021201</creationdate><title>Oncogenic ras alters sensitivity of mouse colonocytes to butyrate and fatty acid mediated growth arrest and apoptosis</title><author>Turner, Nancy D ; Zhang, Jianhu ; Davidson, Laurie A ; Lupton, Joanne R ; Chapkin, Robert S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-da0515827b60bd07bde6e85b7194214bb5d62a28fe921548fc70a226c9fdea813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Butyrate</topic><topic>Butyrates - pharmacology</topic><topic>Cell culture</topic><topic>Cell Division - drug effects</topic><topic>Cell growth</topic><topic>Chemotherapy</topic><topic>Colon - cytology</topic><topic>Colon - drug effects</topic><topic>Colon cancer</topic><topic>Colorectal cancer</topic><topic>Deoxyribonucleic acid</topic><topic>Dietary fiber</topic><topic>Dissemination</topic><topic>DNA</topic><topic>DNA Adducts - metabolism</topic><topic>Docosahexaenoic acid</topic><topic>Docosahexaenoic Acids - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Experiments</topic><topic>Fatty acids</topic><topic>Fatty Acids, Omega-3</topic><topic>Fatty Acids, Unsaturated - pharmacology</topic><topic>Fish oils</topic><topic>Genes, ras - physiology</topic><topic>Linoleic acid</topic><topic>Linoleic Acid - pharmacology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Pharmacology. Drug treatments</topic><topic>Proliferation</topic><topic>Ras</topic><topic>Space life sciences</topic><topic>Triglycerides - pharmacology</topic><topic>Tumor cell</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Turner, Nancy D</creatorcontrib><creatorcontrib>Zhang, Jianhu</creatorcontrib><creatorcontrib>Davidson, Laurie A</creatorcontrib><creatorcontrib>Lupton, Joanne R</creatorcontrib><creatorcontrib>Chapkin, Robert S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Turner, Nancy D</au><au>Zhang, Jianhu</au><au>Davidson, Laurie A</au><au>Lupton, Joanne R</au><au>Chapkin, Robert S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oncogenic ras alters sensitivity of mouse colonocytes to butyrate and fatty acid mediated growth arrest and apoptosis</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2002-12-01</date><risdate>2002</risdate><volume>186</volume><issue>1</issue><spage>29</spage><epage>35</epage><pages>29-35</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><abstract>Docosahexaenoic acid (DHA) and butyrate favorably modulate colonocyte proliferation and apoptosis. In order to elucidate how oncogenic Ras modulates responses to these chemopreventive nutrients, we incubated isogenic non-transformed and Ras malignant transformed mouse colon cells with butyrate and DHA or linoleic acid (LA). Combining DHA with 1 mM butyrate decreased proliferation relative to LA or no PUFA treatment in both cell lines. At a higher butyrate dose (5 mM), caspase 3 activity was elevated to a greater extent in Ras transformed cells. Only non-transformed cells were sensitive to the apoptogenic effects of DHA, indicating that Ras transformation alters sensitivity to dietary chemopreventive agents.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>12183072</pmid><doi>10.1016/S0304-3835(02)00325-7</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2002-12, Vol.186 (1), p.29-35
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_72016652
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Antineoplastic agents
Apoptosis
Apoptosis - drug effects
Biological and medical sciences
Butyrate
Butyrates - pharmacology
Cell culture
Cell Division - drug effects
Cell growth
Chemotherapy
Colon - cytology
Colon - drug effects
Colon cancer
Colorectal cancer
Deoxyribonucleic acid
Dietary fiber
Dissemination
DNA
DNA Adducts - metabolism
Docosahexaenoic acid
Docosahexaenoic Acids - pharmacology
Dose-Response Relationship, Drug
Experiments
Fatty acids
Fatty Acids, Omega-3
Fatty Acids, Unsaturated - pharmacology
Fish oils
Genes, ras - physiology
Linoleic acid
Linoleic Acid - pharmacology
Medical sciences
Mice
Pharmacology. Drug treatments
Proliferation
Ras
Space life sciences
Triglycerides - pharmacology
Tumor cell
Tumors
title Oncogenic ras alters sensitivity of mouse colonocytes to butyrate and fatty acid mediated growth arrest and apoptosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A15%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oncogenic%20ras%20alters%20sensitivity%20of%20mouse%20colonocytes%20to%20butyrate%20and%20fatty%20acid%20mediated%20growth%20arrest%20and%20apoptosis&rft.jtitle=Cancer%20letters&rft.au=Turner,%20Nancy%20D&rft.date=2002-12-01&rft.volume=186&rft.issue=1&rft.spage=29&rft.epage=35&rft.pages=29-35&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/10.1016/S0304-3835(02)00325-7&rft_dat=%3Cproquest_cross%3E3241471321%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1505362304&rft_id=info:pmid/12183072&rft_els_id=S0304383502003257&rfr_iscdi=true